Trial Profile
Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 26 Jun 2017 Status changed from active, no longer recruiting to completed.
- 04 Dec 2015 Planned End Date changed from 1 Jul 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov.
- 29 Oct 2013 Planned end date changed from 1 Jul 2013 to 1 Jul 2014 as reported by ClinicalTrials.gov.